|
|
|
| Effect of Budesonide Combined with Compound Ipratropium Bromide on TNF-α MMP-9 and PCT in Children with Mycoplasma Pneumonia |
| XING Yaming, WANG Fengjuan, ZHANG Jing |
| Liaoyang Central Hospital, Liaoning Liaoyang 111000, China |
|
|
|
|
Abstract Objective: To explore the effect of budesonide combined with compound ipratropium bromide on tumor necrosis factor - α (TNF-α), matrix metalloproteinase-9 (MMP-9), procalcitonin (PCT) in children with mycoplasma pneumonia. Methods: A total of 70 children with MPP who were treated in our hospital from June 2016 to June 2020 were enrolled and divided into an observation group of 35 cases and a control group of 35 cases by stratified random grouping. The control group received compound ipratropium bromide spray for 1 month. In the treatment with chemical solution, the observation group was treated with budesonide combined with compound ipratropium bromide nebulized solution for 1 month. The clinical efficacy, the levels of serum TNF-α, MMP-9 and PCT before and after treatment, and the incidence of adverse reactions of the two groups were compared. Results: Compared with the control group (71.43%), the total clinical effective rate (94.29%) of the observation group was significantly higher, and the difference was statistically significant (P<0.05); after treatment, the two groups of serum TNF-α, MMP-9, The PCT level was significantly reduced, and the reduction in the observation group was significantly greater than that in the control group; the difference was statistically significant (P<0.05). During the treatment, there was no significant difference in the incidence rate of adverse reactions between the two groups (P>0.05). Conclusion: Budesonide combined with compound ipratropium bromide aerosol in the treatment of pediatric MPP can significantly improve its clinical effect, and is closely related to TNF-α, MMP-9, PCT, and has a higher clinical treatment for pediatric MPP Reference value.
|
|
|
|
|
|
[1] DavidAguileraAlonso,RocioLopez Ruiz,JoseCenteno Rubiano,et al.Epidemiological and clinical analysis of community-acquired mycoplasma pneumonia in children from a spanish population,2010~2015[J].An Pediatr,2019,91( 1):21~29.
[2] 曹燕玲,高娇娇,李文斌,等.血浆Ficolin-3水平与肺炎支原体感染患儿疾病分期及病情程度的相关性分析[J].河北医学,2020,26(4):693~697.
[3] 王晔华,杜红琴.孟鲁司特钠联合盐酸氨溴索对肺炎支原体肺炎患儿免疫功能和炎性因子的影响[J].中国基层医药,2020,27(24):3030~3034.
[4] 韩红,安红,高超,等.呼出气一氧化氮与血清hs-CRP、sB7-H3联合检测在儿童肺炎支原体肺炎中的诊断价值[J].河北医科大学学报,2020,41(7):838~840.
[5] Cao B,Qi X X,Zhang J M.Effect of vitamin D3 on NF-κB and MMP-9 expression in lungs of mice infected with mycoplasma pneumonia[J].Anat Res,2018,6(4): 729~732.
[6] 胡亚美,江载芳.实用儿科学[M].第7版.北京:人民卫生出版社,2003.1204~1205.
[7] Man G,Kuo W,Mingyue Y,et al.Transcriptome analysis of bronchoalveolar lavage fluid from children with mycoplasma pneumoniae pneumonia reveals natural killer and T cell-proliferationresponses[J].Front Immunol,2018,9(1):1403~1405.
[8] 黄芳,陈虹.吸入用布地奈德混悬液联合吸入用复方异丙托溴铵溶液治疗小儿急性支气管炎的疗效观察[J].中国医院用药评价与分析,2018,18(2): 187~189.
[9] Wang J Y.Clinical study on treatment of infantile wheezing with 3% hypertonic saline combined with budesonide,Ipratropium bromide and albuterol atomization inhalation[J].Med Forum,2019,9(12): 326~330. |
|
|
|
2021, Vol. 27 
